Impact of Pharmacogenetic Markers of CYP2B6, Clinical Factors, and Drug-Drug Interaction on Efavirenz Concentrations in HIV/Tuberculosis-Coinfected Patients

Comprehensive information on the effects of cytochrome P450 2B6 (CYP2B6) polymorphisms, clinical factors, and drug-drug interactions on efavirenz concentrations in HIV/tuberculosis-coinfected (HIV/TB) patients is unavailable. A total of 139 HIV/TB adults, 101 of whom received a rifampin-containing a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Manosuthi, Weerawat, Sukasem, Chonlaphat, Lueangniyomkul, Aroon, Mankatitham, Wiroj, Thongyen, Supeda, Nilkamhang, Samruay, Manosuthi, Sukanya, Sungkanuparph, Somnuek
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2013
Gaiak:
Clinical Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553682/
https://ncbi.nlm.nih.gov/pubmed/23254426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02023-12
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak